Screener
Fulgent Genetics, Inc. FLGT Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $23,399 | $50,193 |
| Marketable securities | 252,903 | 285,884 |
| Trade accounts receivable, net of allowance for credit losses of $21,420 as of March 31, 2026, and $21,411 as of December 31, 2025 | 69,277 | 84,762 |
| Prepaid income taxes | 109,165 | 107,099 |
| Other current assets | 24,298 | 22,552 |
| Total current assets | 479,042 | 550,490 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s short-term investments?
- Fulgent Genetics, Inc. (FLGT) reported short-term investments of $252.9M in Q1 2026.
- What is the long-term trend for Fulgent Genetics, Inc.'s short-term investments?
- Over 2 years (2020 to 2025), Fulgent Genetics, Inc.'s short-term investments has grown at a 16.1% compound annual growth rate (CAGR), from $211.94M to $285.88M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Fulgent Genetics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude